NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



Research on tuberculosis described by X. Shen and colleagues



March 3rd, 2009

According to recent research from Shanghai, People's Republic of China, "During 2000-2006, a regional anti-tuberculosis drug resistance surveillance study was conducted in Shanghai, China. To determine the prevalence, trends and risk factors for drug-resistant tuberculosis (TB) in Shanghai, China."

"A retrospective study of all pulmonary TB patients reported in Shanghai during 2000-2006 was conducted. Of 8419 pulmonary TB patients, 16.6% had resistance to any first-line anti-tuberculosis drug and 4.0% had multidrug resistance (MDR). The percentage of TB patients with resistance to any first-line anti-tuberculosis drug and MDR significantly increased during 2000-2003 (P...


Source: TB & Outbreaks Week (2009-03-03)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login